General
Preferred name
ESTROPIPATE
Synonyms
Estrone sulfate piperazine salt ()
Piperazine estrone sulfate ()
Pipestrone ()
Piperazine estrone sulfate, Estrone sulfate piperazine salt, Pipestrone ()
Ortho-est ()
NSC-758912 ()
Ogen 5 ()
Ogen ()
Ogen 2.5 ()
Piperazine estrone sulphate ()
Sulestrex piperazine ()
Ogen 1.25 ()
Ogen .625 ()
Harmogen ()
estrogen ()
P&D ID
PD012003
CAS
7280-37-7
Tags
natural product
drug
available
Drug indication
Hypogonadism
Drug Status
approved
Max Phase
Phase 4
First approval
1977
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
9
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugMAP
DrugMAP Approved Drugs
MedChem Express Bioactive Compound Library
Prestwick Chemical Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
16
Properties
(calculated by RDKit )
Molecular Weight
436.2
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
3
Rotatable Bonds
2
Ring Count
5
Aromatic Ring Count
1
cLogP
2.47
TPSA
104.73
Fraction CSP3
0.68
Chiral centers
4.0
Largest ring
6.0
QED
0.61
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Endocrinology/Hormones
Vitamin D Related/Nuclear Receptor
Target
ER
Estrogen Receptor/ERR
Estrogen/progestogen Receptor
Source data
